Category: New products
-
Small Biz Award to Boost Maternal Health App
A digital health company with an app for monitoring maternal health is receiving nearly $1 million to add an algorithm for detecting a dangerous pregnancy complication.
-
One-Time Crispr HIV Therapy Given Fast-Track Status
A treatment for HIV taken just once, using the genome-editing technology Crispr, is receiving fast-track designation from the U.S. Food and Drug Administration.
-
Darpa Seeking On-Demand, Distributed Production of Proteins
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins.
-
Trial Underway Testing Engineered Cancer-Killing Viruses
A clinical trial, testing stem cells for neurons fortified with tumor-killing viruses, administered its first doses to a patient with glioma, an aggressive type of brain cancer.
-
NIH Funding Single Home Test for Covid-19, Influenza, RSV
A developer of diagnostics for infectious and other diseases is receiving a National Institutes of Health contract to advance a single at-home test for multiple respiratory diseases.
-
Trial Underway Testing Dried Plasma for Transfusions
A clinical trial is recruiting participants to assess the safety and feasibility of a system for spray drying and re-constituting a person’s blood plasma.
-
Digital Biomarkers Shown to Highlight Parkinson’s Disease
Early findings indicate calculations from MRI scans of white matter lesions in the brain can distinguish between Parkinson’s disease and other neurological conditions.
-
A.I.-Enhanced Sensors Start-Up Gains $10.5M in Early Funds
A company developing area sensors for smart homes that combine WiFi technology with machine learning algorithms is raising $10.5 million in venture funds.
-
Biochip Device Tests Malaria Drug Efficacy, Safety
A lab-on-a-chip device with human organ cells is shown in lab tests to distinguish between malaria strains and detect drug toxicity when assessing blood for seven days.
-
Synthetic DNA Company Gains $10M in Venture Round
A company using a process it says can produce synthetic genes with greater accuracy for research and clinical applications is raising $10 million in its first venture round.